Partner Headlines - PGNX

  1. Progenics Receives $40M Milestone Following FDA Approval of RELISTOR ...

    Benzinga
  2. Morning Market Losers

    Benzinga
  3. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  4. Earnings Scheduled For August 8, 2014

    Benzinga
  5. Morning Market Movers

    Benzinga
  6. Benzinga's Top #PreMarket Gainers

    Benzinga
  7. US Stock Futures Surge; All Eyes On Citigroup Results

    Benzinga
  8. UPDATE: Salix, Progenics Report FDA Office Of Drug Evaluation ...

    Benzinga
  9. Progenics Announces Will Host Call Related to FDA Appeal Response ...

    Benzinga
  10. Progenics, Nektar Still Halted; FDA Advisory Committee Expected ...

    Benzinga
  11. Small Pharmaceuticals Rallying Following FDA Report

    Benzinga
  12. Mid-Afternoon Market Update; Hertz Down, QuikSilver Gain On CEO ...

    Benzinga
  13. Mid-Day Market Update: Diamond Foods Shares Fall After Weak Earnings; ...

    Benzinga
  14. Earnings Scheduled For May 9, 2014

    Benzinga
  15. Progenics Pharmaceuticals Announces Completion of Enrollment ...

    Benzinga
  16. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  17. Salix Pharmaceuticals, Progenics Pharmaceuticals Announce the ...

    Benzinga
  18. Earnings Scheduled For March 13, 2014

    Benzinga
  19. 2 Deaths, 25% Plunge -- And Still A Big Upside

    YCharts
  20. Progenics Pharmaceuticals Announces the Appointment of Karen ...

    Benzinga
  21. Progenics Pharmaceuticals Relaunches Registrational Trial of ...

    Benzinga
  22. Earnings Scheduled For November 11, 2013

    Benzinga
  23. Salix Pharmaceuticals Thrives With Promising GI Drugs

    IBD
  24. Weekly CEO Buys Highlight: CVRR, HBAN, VVTV, SXCP, PGNX

    GuruFocus
  25. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  26. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  27. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  28. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  29. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  30. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  31. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  32. Progenics Pharmaceuticals, Inc. (PGNX) CEO Mark Robert Baker ...

    GuruFocus
  33. Weekly CEO Buys Highlight: SUSP, ROVI, ZLC, MDW, PGNX

    GuruFocus
  34. Progenics Pharmaceuticals Inc. (PGNX) CEO Mark Robert Baker buys ...

    GuruFocus
  35. 5 Stocks That Dropped the Most Since Gurus Bought Them

    GuruFocus
  36. EZchip Semiconductor, Sagent Pharmaceuticals Among Stocks setting ...

    FoxBusiness
  37. Salix trounces Q2 estimates

    IBD
  38. Progenics Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  39. Salix Pharmaceuticals Beats, Announces Licensing Deal

    IBD
  40. ProShares Trust Ultra VIX Short Term Futures ETF, Direxion Daily ...

    FoxBusiness
  41. Stocks Finish Little Changed Ahead of Central Bank Meetings with ...

    MarketIntelligenceCenter
  42. Salix, Progenics Stocks Fall On Drug Approval Delay

    IBD
  43. Stock Futures Mixed; Salix, Progenics Tumble

    IBD
  44. Benzinga's Top Pre-Market Losers

    Benzinga
  45. Financial Breakfast: Morning News Summary for July 30, 2012

    Benzinga
  46. Salix Q1 Results Beat Estimates; Raises EPS Guidance

    IBD
  47. Microcap Movers for Tuesday December 20, 2011

    Benzinga
  48. Stocks Bounce Back In Big Volume

    IBD
  49. Progenics Pharma Up 30% on Positive Phase 3 Results

    Benzinga
  50. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
  51. Morning Market Movers

    Benzinga
  52. Progenics Pharmaceuticals Lures Call Players in the Options Pits

    SchaeffersResearch
  53. Notable Call Options Activity in Progenics Pharmaceuticals

    Benzinga
Trading Center